Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders

Proteomics - Clinical Applications

Volumn 6, Issue 1-2, 2012, Pages 91-101

  Lehr, Stefan ^a   Hartwig, Sonja ^a   Sell, Henrike ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Adipokines; Adipose tissue; Organ crosstalk; Proteomic profiling; Secretome

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; SECRETORY PROTEIN;

ADIPOSE TISSUE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOCRINE GLAND; HUMAN; METABOLIC DISORDER; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ADIPOKINES; ADIPOSE TISSUE; BIOLOGICAL MARKERS; HUMANS; METABOLIC DISEASES; PROTEOMICS;

EID: 84858964200     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201100052     Document Type: Review

References (129)

1. Misra, A., Khurana, L., Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 2008, 93, S9-S30.
2. Shaw, J., Epidemiology of childhood type 2 diabetes and obesity. Pediatr. Diabetes 2007, 8, 7-15.
3. Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z. et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640-1645.
4. Golay, A., Ybarra, J., Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19, 649-663.
5. Moore, J. B., Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc. Nutr. Soc. 2010, 69, 211-220.
6. Despres, J. P., Lemieux, I., Bergeron, J., Pibarot, P. et al., Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1039-1049.
7. Anderson, J. W., Kendall, C. W., Jenkins, D. J., Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J. Am. Coll. Nutr. 2003, 22, 331-339.
8. Trayhurn, P., Wood, I. S., Signalling role of adipose tissue: Adipokines and inflammation in obesity. Biochem. Soc. Trans. 2005, 33, 1078-1081.
9. Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M. et al., Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134, 933-944.
10. Trayhurn, P., Drevon, C. A., Eckel, J., Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk. Arch. Physiol. Biochem. 2011, 117, 47-56.
11. Coppack, S. W., Adipose tissue changes in obesity. Biochem. Soc. Trans. 2005, 33, 1049-1052.
12. Lee, D. E., Kehlenbrink, S., Lee, H., Hawkins, M. et al., Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E1210-E1229.
13. Kahn, B. B., Flier, J. S., Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-481.
14. Taube, A., Eckardt, K., Eckel, J., Role of lipid-derived mediators in skeletal muscle insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2009. [Epub ahead of print].
15. Despres, J. P., Lemieux, I., Abdominal obesity and metabolic syndrome. Nature 2006, 444, 881-887.
16. Mathieu, P., Poirier, P., Pibarot, P., Lemieux, I. et al., Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009, 53, 577-584.
17. Guilherme, A., Virbasius, J. V., Puri, V., Czech, M. P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 2008, 9, 367-377.
18. Van Harmelen, V., Reynisdottir, S., Eriksson, P., Thorne, A. et al., Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998, 47, 913-917.
19. Motoshima, H., Wu, X., Sinha, M. K., Hardy, V. E. et al., Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J. Clin. Endocrinol. Metab. 2002, 87, 5662-5667.
20. Bruun, J. M., Lihn, A. S., Pedersen, S. B., Richelsen, B., Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 2005, 90, 2282-2289.
21. van Herpen, N. A., Schrauwen-Hinderling, V. B., Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol. Behav. 2008, 94, 231-241.
22. Krssak, M., Falk, P. K., Dresner, A., DiPietro, L. et al., Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999, 42, 113-116.
23. Haufe, S., Engeli, S., Budziarek, P., Utz, W. et al., Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes 2010, 59, 1640-1647.
24. Sell, H., Eckel, J., Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? Proc. Nutr. Soc. 2009, 68, 378-384.
25. Sell, H., Eckel, J., Adipose tissue inflammation: Novel insight into the role of macrophages and lymphocytes. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 366-370.
26. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
27. Curat, C. A., Miranville, A., Sengenes, C., Diehl, M. et al., From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53, 1285-1292.
28. Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. et al., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145, 2273-2282.
29. Yudkin, J. S., Eringa, E., Stehouwer, C. D., ''Vasocrine'' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005, 365, 1817-1820.
30. Ouwens, D. M., Sell, H., Greulich, S., Eckel, J., The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J. Cell. Mol. Med. 2010, 14, 2223-2234.
31. Scherer, P. E., Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55, 1537-1545.
32. Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
33. Moller, D. E., Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol. Metab. 2000, 11, 212-217.
34. Halse, R., Pearson, S. L., McCormack, J. G., Yeaman, S. J. et al., Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 2001, 50, 1102-1109.
35. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. et al., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95, 2409-2415.
36. Keller, P., Keller, C., Carey, A. L., Jauffred, S. et al., Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem. Biophys. Res. Commun. 2003, 310, 550-554.
37. Carey, A. L., Febbraio, M. A., Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia 2004, 47, 1135-1142.
38. Sartipy, P., Loskutoff, D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100, 7265-7270.
39. Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S. et al., Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 2003, 278, 46654-46660.
40. Fruhbeck, G., Peripheral actions of leptin and its involvement in disease. Nutr. Rev. 2002, 60, S47-S55.
41. Arch, J. R., Central regulation of energy balance: Inputs, outputs and leptin resistance. Proc. Nutr. Soc. 2005, 64, 39-46.
42. Tschritter, O., Fritsche, A., Thamer, C., Haap, M. et al., Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52, 239-243.
43. Dietze-Schroeder, D., Sell, H., Uhlig, M., Koenen, M. et al., Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005, 54, 2003-2011.
44. Lamers, D., Schlich, R., Greulich, S., Sasson, S. et al., Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J. Cell. Mol. Med. 2011, 15, 1177-1188.
45. Satoh, H., Nguyen, M. T., Trujillo, M., Imamura, T. et al., Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats. Diabetes 2005, 54, 1304-1313.
46. Arita, Y., Kihara, S., Ouchi, N., Maeda, K. et al., Adipocytederived plasma protein adiponectin acts as a plateletderived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105, 2893-2898.
47. Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M. et al., Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106, 2767-2770.
48. Herder, C., Baumert, J., Thorand, B., Koenig, W. et al., Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 2006, 49, 921-929.
49. Schernthaner, G. H., Kopp, H. P., Kriwanek, S., Krzyzanowska, K. et al., Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes. Surg. 2006, 16, 709-715.
50. Sell, H., Dietze-Schroeder, D., Kaiser, U., Eckel, J., Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147, 2458-2467.
51. Marinou, K., Tousoulis, D., Antonopoulos, A. S., Stefanadi, E. et al., Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int. J. Cardiol. 2010, 138, 3-8.
52. Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Sr., Benjamin, E. J. et al., Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J. Am. Coll. Cardiol. 2009, 53, 754-762.
53. Goldstein, B. J., Scalia, R. G., Ma, X. L., Protective vascular and myocardial effects of adiponectin. Nat. Clin. Pract. Cardiovasc. Med. 2009, 6, 27-35.
54. Sweeney, G., Cardiovascular effects of leptin. Nat. Rev. Cardiol. 2010, 7, 22-29.
55. Ford, E. S., The epidemiology of obesity and asthma. J. Allergy Clin. Immunol. 2005, 115, 897-909.
56. Shore, S. A., Rivera-Sanchez, Y. M., Schwartzman, I. N., Johnston, R. A., Responses to ozone are increased in obese mice. J. Appl. Physiol. 2003, 95, 938-945.
57. Sood, A., Dawson, B. K., Eid, W., Eagleton, L. E. et al., Obesity is associated with bronchial hyper-responsiveness in women. J. Asthma 2005, 42, 847-852.
58. Shore, S. A., Schwartzman, I. N., Mellema, M. S., Flynt, L. et al., Effect of leptin on allergic airway responses in mice. J. Allergy Clin. Immunol. 2005, 115, 103-109.
59. Shore, S. A., Terry, R. D., Flynt, L., Xu, A. et al., Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 2006, 118, 389-395.
60. Bluher, M., The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr. Opin. Lipidol. 2010, 21, 38-43.
61. Kloting, N., Fasshauer, M., Dietrich, A., Kovacs, P. et al., Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. etab. 2010, 299, E506-E515.
62. Joffe, B. I., Panz, V. R., Raal, F. J., From lipodystrophy syndromes to diabetes mellitus. Lancet 2001, 357, 1379-1381.
63. Halleux, C. M., Takahashi, M., Delporte, M. L., Detry, R. et al., Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem. Biophys. Res. Commun. 2001, 288, 1102-1107.
64. Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J. et al., Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5, 3304-3313.
65. Hartwig, S., Czibere, A., Kotzka, J., Passlack, W. et al., Combinatorial hexapeptide ligand libraries (ProteoMiner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch. Physiol. Biochem. 2009, 115, 155-160.
66. Bjorhall, K., Miliotis, T., Davidsson, P., Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5, 307-317.
67. Darde, V. M., Barderas, M. G., Vivanco, F., Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis. Methods Mol. Biol. 2007, 357, 351-364.
68. Guerrier, L., Righetti, P. G., Boschetti, E., Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library. Nat. Protoc. 2008, 3, 883-890.
69. Shen, Y., Kim, J., Strittmatter, E. F., Jacobs, J. M. et al., Characterization of the human blood plasma proteome. Proteomics 2005, 5, 4034-4045.
70. Granger, J., Siddiqui, J., Copeland, S., Remick, D., Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005, 5, 4713-4718.
71. Orci, L., Tagaya, M., Amherdt, M., Perrelet, A. et al., Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell 1991, 64, 1183-1195.
72. Hughes, R. C., Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim.
73. Biophys. Acta 1999, 1473, 172-185.
74. Bradley, R. L., Cleveland, K. A., Cheatham, B., The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. Recent. Prog. Horm. Res. 2001, 56, 329-358.
75. Lamers, D., Famulla, S., Wronkowitz, N., Hartwig, S. et al., Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011, 60, 1917-1925.
76. Ibarrola, N., Kalume, D. E., Gronborg, M., Iwahori, A. et al., A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal. Chem. 2003, 75, 6043-6049.
77. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
78. Ong, S. E., Kratchmarova, I., Mann, M., Properties of 13Csubstituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J. Proteome Res. 2003, 2, 173-181.
79. Ong, S. E., Mann, M., A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc. 2006, 1, 2650-2660.
80. Burton, G. R., Guan, Y., Nagarajan, R., McGehee, R. E., Jr. Microarray analysis of gene expression during early adipocyte differentiation. Gene 2002, 293, 21-31.
81. Gregoire, F. M., Smas, C. M., Sul, H. S., Understanding adipocyte differentiation. Physiol. Rev. 1998, 78, 783-809.
82. MacDougald, O. A., Cornelius, P., Lin, F. T., Chen, S. S. et al., Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue. J. Biol. Chem. 1994, 269, 19041-19047.
83. Soukas, A., Socci, N. D., Saatkamp, B. D., Novelli, S. et al., Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J. Biol. Chem. 2001, 276, 34167-34174.
84. Kratchmarova, I., Kalume, D. E., Blagoev, B., Scherer, P. E. et al., A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 2002, 1, 213-222.
85. Wang, P., Mariman, E., Keijer, J., Bouwman, F. et al., Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell. Mol. Life Sci. 2004, 61, 2405-2417.
86. Lafon-Cazal, M., Adjali, O., Galeotti, N., Poncet, J. et al., Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J. Biol. Chem. 2003, 278, 24438-24448.
87. Greco, T. M., Seeholzer, S. H., Mak, A., Spruce, L. et al., Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion. J. Proteome Res. 2010, 9, 2764-2774.
88. Molina, H., Yang, Y., Ruch, T., Kim, J. W. et al., Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy. J. Proteome Res. 2009, 8, 48-58.
89. Flory, M. R., Griffin, T. J., Martin, D., Aebersold, R., Advances in quantitative proteomics using stable isotope tags. Trends Biotechnol. 2002, 20, S23-S29.
90. Mirgorodskaya, O. A., Kozmin, Y. P., Titov, M. I., Korner, R. et al., Quantitation of peptides and proteins by matrixassisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom. 2000, 14, 1226-1232.
91. Reynolds, K. J., Yao, X., Fenselau, C., Proteolytic 18O labeling for comparative proteomics: evaluation of endoprotease Glu-C as the catalytic agent. J. Proteome Res. 2002, 1, 27-33.
92. Stewart, I. I., Thomson, T., Figeys, D., 18O labeling: A tool for proteomics. Rapid Commun. Mass Spectrom. 2001, 15, 2456-2465.
93. Yao, X., Freas, A., Ramirez, J., Demirev, P. A. et al., Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 2001, 73, 2836-2842.
94. Chen, X., Cushman, S. W., Pannell, L. K., Hess, S., Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography- MS/MS approach. J. Proteome Res. 2005, 4, 570-577.
95. Hess, S., van Beek, J., Pannell, L. K., Acid hydrolysis of silk fibroins and determination of the enrichment of isotopically labeled amino acids using precolumn derivatization and high-performance liquid chromatography-electrospray ionization-mass spectrometry. Anal. Biochem. 2002, 311, 19-26.
96. Schnolzer, M., Jedrzejewski, P., Lehmann, W. D., Proteasecatalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 1996, 17, 945-953.
97. Shevchenko, A., Chernushevich, I., Ens,W., Standing, K. G. et al., Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 1997, 11, 1015-1024.
98. Yao, X., Afonso, C., Fenselau, C., Dissection of proteolytic 18O labeling: endoprotease-catalyzed 16O-to-18O exchange of truncated peptide substrates. J. Proteome Res. 2003, 2, 147-152.
99. Roca-Rivada, A., Alonso, J., Al-Massadi, O., Castelao, C. et al., Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. J. Proteomics 2011, 74, 1068-1079.
100. Celis, J. E., Moreira, J. M., Cabezon, T., Gromov, P. et al., Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 2005, 4, 492-522.
101. Zvonic, S., Lefevre, M., Kilroy, G., Floyd, Z. E. et al., Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol. Cell. Proteomics 2007, 6, 18-28.
102. Mitchell, J. B., McIntosh, K., Zvonic, S., Garrett, S. et al., Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cellassociated markers. Stem Cells 2006, 24, 376-385.
103. Alvarez-Llamas, G., Szalowska, E., de Vries, M. P., Weening, D. et al., Characterization of the human visceral adipose tissue secretome. Mol. Cell. Proteomics 2007, 6, 589-600.
104. Nielsen, H., Brunak, S., von Heijne, G., Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng. 1999, 12, 3-9.
105. Bendtsen, J. D., Jensen, L. J., Blom, N., von Heijne, H. G. et al., Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 2004, 17, 349-356.
106. Roelofsen, H., Dijkstra, M.,Weening, D., de Vries, M. P. et al., Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Mol. Cell. Proteomics 2009, 8, 316-324.
107. Mutch, D. M., Rouault, C., Keophiphath, M., Lacasa, D. et al., Using gene expression to predict the secretome of differentiating human preadipocytes. Int. J. Obes. (Lond) 2009, 33, 354-363.
108. Kim, J., Choi, Y. S., Lim, S., Yea, K. et al., Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 2010, 10, 394-405.
109. Griffin, N. M., Yu, J., Long, F., Oh, P. et al., Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol. 2010, 28, 83-89.
110. Hendrickson, E. L., Xia, Q., Wang, T., Leigh, J. A. et al., Comparison of spectral counting and metabolic stable isotope labeling for use with quantitative microbial proteomics. Analyst 2006, 131, 1335-1341.
111. Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G. et al., Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 2005, 4, 1487-1502.
112. Zhang, B., VerBerkmoes, N. C., Langston, M. A., Uberbacher, E. et al., Detecting differential and correlated protein expression in label-free shotgun proteomics. J. Proteome Res. 2006, 5, 2909-2918.
113. Lee, M. J., Kim, J., Kim, M. Y., Bae, Y. S. et al., Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J. Proteome Res. 2010, 9, 1754-1762.
114. Zhong, J., Krawczyk, S. A., Chaerkady, R., Huang, H. et al., Temporal profiling of the secretome during adipogenesis in humans. J. Proteome Res. 2010, 9, 5228-5238.
115. Yang, Y., Chaerkady, R., Beer, M. A., Mendell, J. T. et al., Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009, 9, 1374-1384.
116. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
117. Vazquez-Martin, A., Colomer, R., Menendez, J. A., Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Eur. J. Cancer 2007, 43, 1117-1124.
118. Grisanti, L. A., Evanson, J., Marchus, E., Jorissen, H. et al., Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. Mol. Immunol. 2010, 47, 1244-1254.
119. Yu, X., Schneiderhan-Marra, N., Hsu, H. Y., Bachmann, J. et al., Protein microarrays: effective tools for the study of inflammatory diseases. Methods Mol. Biol. 2009, 577, 199-214.
120. Rosenow, A., Arrey, T. N., Bouwman, F. G., Noben, J. P. et al., Identification of novel human adipocyte secreted proteins by using SGBS cells. J. Proteome Res. 2010, 9, 5389-5401.
121. Wabitsch, M., Brenner, R. E., Melzner, I., Braun, M. et al., Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 8-15.
122. Unlu, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
123. Asirvatham, V. S., Watson, B. S., Sumner, L. W., Analytical and biological variances associated with proteomic studies of Medicago truncatula by two-dimensional polyacrylamide gel electrophoresis. Proteomics 2002, 2, 960-968.
124. Gade, D., Thiermann, J., Markowsky, D., Rabus, R., Evaluation of two-dimensional difference gel electrophoresis for protein profiling. Soluble proteins of the marine bacterium Pirellula sp. strain 1. J. Mol. Microbiol. Biotechnol. 2003, 5, 240-251.
125. Famulla, S., Lamers, D., Hartwig, S., Passlack, W. et al., Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int. J. Obes. (Lond) 2011, 35, 762-772.
126. Hida, K., Wada, J., Eguchi, J., Zhang, H. et al., Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 2005, 102, 10610-10615.
127. Boucher, J., Masri, B., Daviaud, D., Gesta, S. et al., Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146, 1764-1771.
128. Lang, P., van Harmelen, V., Ryden, M., Kaaman, M. et al., Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS One 2008, 3, e1713.
129. Crowe, S., Wu, L. E., Economou, C., Turpin, S. M. et al., Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab. 2009, 10, 40-47.